Evidence map›Paper›PMID 35298025›Full record

ArticleCA: a cancer journal for clinicians2022

Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review.

Deborah C Marshall, Elizabeth S Tarras, Ayesha Ali, Julie Bloom, Mylin A Torres, Jenna M Kahn

Open access · diamondAbstract readScoping Review
In one paragraph

Article in CA: a cancer journal for clinicians, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Sex-Based Bias in Artificial Intelligence-Based Segmentation Models in Clinical Oncology.Clinical oncology (Royal College of Radiologists (Great Britain)) · 2025
    Review
  10. Review
  11. Article
  12. Review
  13. Role of Nutraceuticals in Treating Erectile DysfunctionCurrent pharmaceutical biotechnology · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. The mMolecular cancer · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Deborah C MarshallDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.ORCID 0000-0002-6675-7482
Elizabeth S TarrasNew York University School of Medicine, New York, New York.
Ayesha AliDepartment of Radiation Oncology, Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania.
Julie BloomDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Mylin A TorresDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia.
Jenna M KahnOregon Health and Sciences University, Portland, Oregon.
Icahn School of Medicine at Mount Sinai · USEmory University · USNew York University · USOregon Health & Science University · USThomas Jefferson University Hospital · US

Funding

NRG Oncology NCORP Research Base-BIQSFPUG1CA189867 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Deborah Watkins Bruner, Lisa A. Kachnic · 2014 to 2026
$140.5M
Training Program in Cancer Prevention and Control for Priority PopulationsT32CA225617 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Guy H Montgomery, JUAN P WISNIVESKY · 2018 to 2026
$2.6M
Novel Functional Anatomic and Biomarker Indices of Radiation-Induced Female Sexual Toxicities in a Multi-Center CohortDP5OD031876 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MARSHALL, DEBORAH CATHERINE · 2021 to 2025
$2.1M
NCI NIH HHS T32 CA225617NCI NIH HHS UG1 CA189867NIH HHS DP5 OD031876
6 · The paper itself

Abstract

Sexual function is a vital aspect of human health and is recognized as a critical component of cancer survivorship. Understanding and evaluating the impacts of radiotherapy on female sexual function requires precise knowledge of the organs involved in sexual function and the relationship between radiotherapy exposure and sexual tissue function. Although substantial evidence exists describing the impact of radiotherapy on male erectile tissues and related clinical sexual outcomes, there is very little research in this area in females. The lack of biomedical data in female patients makes it difficult to design studies aimed at optimizing sexual function postradiotherapy for female pelvic malignancies. This scoping review identifies and categorizes current research on the impacts of radiotherapy on normal female erectile tissues, including damage to normal functioning, clinical outcomes of radiation-related female erectile tissue damage, and techniques to spare erectile tissues or therapies to treat such damage. An evaluation of the evidence was performed, and a summary of findings was generated according to Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) Extension for Scoping Reviews guidelines. Articles were included in the review that involved normal female erectile tissues and radiotherapy side effects. The results show that little scientific investigation into the impacts of radiotherapy on female erectile tissues has been performed. Collaborative scientific investigations by clinical, basic, and behavioral scientists in oncology and radiotherapy are needed to generate radiobiologic and clinical evidence to advance prospective evaluation, prevention, and mitigation strategies that may improve sexual outcomes in female patients.

Indexed as

Cancer SurvivorsErectile DysfunctionRadiation InjuriesSexual Dysfunction, PhysiologicalFemaleHumansMalePenile Erectioncancerfemale sexual toxicityradiotherapysexual dysfunctionsurvivorship

Identifiers

PMID35298025
PMCPMC9262811
OpenAlexW4220962131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.